Retrospective Study
Copyright ©The Author(s) 2015.
World J Cardiol. Nov 26, 2015; 7(11): 792-800
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.792
Table 1 Patient demographics and comorbidities
VariableTotal (n = 200)BTT (n = 98)DT (n = 102)P value
Age (yr)54.3 ± 12.550.1 ± 12.858.4 ± 10.70.001
Gender
Female24% (48/200)25.5% (25/98)22.8% (23/102)
Male76% (151/200)74.5% (73/98)76.5% (78/102)0.652
Race
AA46% (92/200)39.8% (39/98)52% (53/102)0.375
Caucasian54% (108/200)54.1% (53/98)42.4% (47/102)
Etiology of heart failure
ICM52% (104/200)29% (28/98)74.5% (76/102)0.001
NIDCM48% (96/200)51% (50/98)45.1% (46/102)
BSA1.97 ± 0.271.96 ± 0.271.98 ± 0.280.667
BMI28.3 ± 5.528.1 ± 4.328.5 ± 6.50.763
Albumin (g/dL)4.14 ± 10.033.19 ± 0.515.06 ± 14.050.015
DM46% (92/200)38.8% (38/98)52.9% (54/102)0.038
HTN83% (166/200)79.6% (78/98)86.2% (88/102)0.153
CRI40% (81/200)29.6% (29/98)51% (52/102)0.002
Dialysis2.5% (5/200)3.1% (3/98)1.8% (2/102)0.680
COPD15.5% (31/200)15.3% (15/98)15.7% (16/102)0.917
PVD12% (23/200)7.1% (7/98)15.7% (16/102)0.055
Vented12% (25/200)9.2% (9/98)15.7% (16/102)0.134
Previous cardiac surgery32% (63/200)20.4% (20/98)42% (43/102)0.001
Creatinine (mg/dL)1.42 ± 0.621.43 ± 0.581.42 ± 0.650.869
AST (U/L)48.3 ± 82.858.0 ± 106.838.9 ± 45.70.212
ALT (U/L)46.5 ± 78.559.8 ± 99.433.5 ± 47.30.002
CPB time (min)113.5 ± 46.1109.5 ± 46.0117.8 ± 46.10.178
XCL time (min)71 ± 30.685.2 ± 33.751.7 ± 26.00.054
MCS at time of VAD18% (36/200)24% (23/98)13% (13/102)0.051
On inotropes at time of VAD75%(150/200)81% (80/98)69% (70/102)0.036
Pre VAD CVP (mmHg)11.8 ± 6.411.6 ± 6.412.0 ± 6.40.653
Pre VAD PAPs (mmHg)51.4 ± 14.250.5 ± 14.552.3 ± 13.80.412
Pre VAD PAPd (mmHg)24.5 ± 9.224.4 ± 9.824.7 ± 8.50.682
Pre Vad CI (L/min per square metre)1.85 ± 0.511.87 ± 0.541.83 ± 0.470.961
Pre VAD PCWP (mmHg)23.0 ± 9.622.7 ± 9.823.4 ± 9.40.463
Blood transfusions23% (46/200)18% (18/98)27% (28/102)0.250
Concomitant cardiac procedure19% (39/200)23% (23/98)15% (16/102)0.137